Carl Pabo

The topic of this article may not meet Wikipedia's notability guideline for biographies. Please help to demonstrate the notability of the topic by citing reliable secondary sources that are independent of the topic and provide significant coverage of it beyond a mere trivial mention. If notability cannot be shown, the article is likely to be merged, redirected, or deleted. Find sources:  –  ·  ·  · scholar · JSTOR (November 2021) (Learn how and when to remove this template message)

Carl O. Pabo is a biophysicist. He is the founder and president of Humanity 2050, a nonprofit institute. ^{[1] [2]}

Education[]

^[3]

• B.S. (summa cum laude) from Yale, Molecular Biophysics and Biochemistry in 1974
• Ph.D. from Harvard, Biochemistry and Molecular Biology in 1980.

Career[]

Dr. Pabo has been a Professor at the Johns Hopkins University School of Medicine (1982-1991) and at the Massachusetts Institute of Technology (1991-2001) and an Investigator with the Howard Hughes Medical Institute (1986-2001).^[4] He's been a Visiting Professor at Caltech, Stanford, Berkeley and Harvard.^[5] At Caltech, he taught a course called “The World in 2050.” ^[6]

He was Chief Scientific Officer at Sangamo BioSciences from 2001–2003.^[7]

In 2018, he founded Humanity 2050 to “to advocate a more comprehensive, coherent way of thinking about the human future.” ^[8] He also serves as a scientific advisor for NanoDimension. ^[9]

Awards, Honors[]

Pabo became a Guggenheim Fellow in 2005.^[10] He is a member of the National Academy of Sciences^[11] and of the American Academy of Arts and Sciences.^[12]

He has also won the Protein Society Young Investigator Award and the Pfizer Award in enzymology.^[13]

References[]

This biographical article related to medicine in the United States is a stub. You can help Wikipedia by .

• v
• t

This article about an American biochemist is a stub. You can help Wikipedia by .

• v
• t